These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 2104627

  • 1. Effect of the circulating renin-angiotensin system on prolactin release in humans.
    Denolle T, Rohmer V, Saint-Adnré JP, Guyene TT, Galland F, Bigorgne JC, Schambelan M, Corvol P.
    J Clin Endocrinol Metab; 1990 Jan; 70(1):288-92. PubMed ID: 2104627
    [Abstract] [Full Text] [Related]

  • 2. The effect of angiotensin-converting enzyme inhibition on prolactin responses in normal and hyperprolactinemic subjects.
    Anderson PW, Malarkey WB, Salk J, Kletsky OA, Hsueh WA.
    J Clin Endocrinol Metab; 1989 Sep; 69(3):518-22. PubMed ID: 2503532
    [Abstract] [Full Text] [Related]

  • 3. Effects of verapamil on diurnal and thyrotropin-releasing hormone-stimulated prolactin levels in man.
    Nielsen-Kudsk JE, Bartels PD, Dalby J.
    J Clin Endocrinol Metab; 1990 May; 70(5):1269-72. PubMed ID: 2110572
    [Abstract] [Full Text] [Related]

  • 4. Presence of renin, angiotensinogen, and converting enzyme in human pituitary lactotroph cells and prolactin adenomas.
    Saint-Andre JP, Rohmer V, Alhenc-Gelas F, Menard J, Bigorgne JC, Corvol P.
    J Clin Endocrinol Metab; 1986 Jul; 63(1):231-7. PubMed ID: 3011840
    [Abstract] [Full Text] [Related]

  • 5. The brain renin-angiotensin system and prolactin secretion in the male rat.
    Myers LS, Steele MK.
    Endocrinology; 1991 Oct; 129(4):1744-8. PubMed ID: 1915064
    [Abstract] [Full Text] [Related]

  • 6. Enhanced response of plasma prolactin to metoclopramide during chronic converting enzyme inhibition.
    Dupont AG, Van der Nipen P, Van Steirteghem AC, Vanhaelst L.
    Horm Metab Res; 1987 May; 19(5):212-5. PubMed ID: 3034757
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin II receptors and prolactin release in pituitary lactotrophs.
    Aguilera G, Hyde CL, Catt KJ.
    Endocrinology; 1982 Oct; 111(4):1045-50. PubMed ID: 6288343
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Liver angiotensinogen synthesis and release during captopril treatment in sodium-depleted rats.
    Jaramillo HN, Sambhi MP, Bouhnik J, Corvol P, Menard J.
    Endocrinology; 1987 Apr; 120(4):1384-90. PubMed ID: 3030698
    [Abstract] [Full Text] [Related]

  • 10. Effect of angiotensin-converting enzyme inhibition on pituitary hormone responses to insulin-induced hypoglycemia in humans.
    Winer LM, Molteni A, Molitch ME.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):256-9. PubMed ID: 2164528
    [Abstract] [Full Text] [Related]

  • 11. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
    Shah GV, Wang W, Grosvenor CE, Crowley WR.
    Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431
    [Abstract] [Full Text] [Related]

  • 12. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE, Gillespie JB.
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [Abstract] [Full Text] [Related]

  • 13. [The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril].
    Jiang M.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):342-4, 396. PubMed ID: 1668233
    [Abstract] [Full Text] [Related]

  • 14. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J, Henik RA, Brownfield M, Armstrong J.
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [Abstract] [Full Text] [Related]

  • 15. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT, Hershman JM, Boyd AE, Longcope C, Bacharach P.
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [Abstract] [Full Text] [Related]

  • 16. The influence of long-term low dose thyrotropin-releasing hormone infusions on serum thyrotropin and prolactin concentrations in man.
    Spencer CA, Greenstadt MA, Wheeler WS, Kletzky OA, Nicoloff JT.
    J Clin Endocrinol Metab; 1980 Oct; 51(4):771-5. PubMed ID: 6774994
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of atropine on the diurnal PRL responses to TRH in normal subjects.
    Nathan RS, McCarthy T, Jarrett DB.
    Psychoneuroendocrinology; 1984 Oct; 9(3):301-4. PubMed ID: 6436857
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.